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Background: Pain, fatigue, and concentration difficulties are typical features of 
chronic fatigue syndrome (CFS). The exact underlying mechanisms of these symptoms 
are still unknown, but available evidence suggests an important role for impaired pain 
modulation. As evidence also suggests that pain modulation is related to cardiovascular 
mechanisms, it seems logical to investigate whether cerebral blood flow (CBF) and heart 
rate variability (HRV) are altered in these patients. 
Objectives: We aimed to investigate the role of the cardiovascular system in pain 
modulation and symptoms of CFS; the response of CBF and HRV to physical stress 
and their relation to the change in temporal summation (TS) of pressure pain and self-
reported symptoms was evaluated.
Study Design: A controlled, randomized cross-over trial.
Setting: University Hospital Brussels.
Methods: Twenty CFS patients and 20 sedentary healthy controls were included in this 
study. In both of the groups, the change in TS of pressure pain, CBF (using transcranial 
Doppler), and HRV (using finger plethysmography) was examined during physical and 
emotional stress (to control for potential bias), as well as their association mutually and 
with self-reported symptoms of pain, fatigue, and concentrations difficulties. 
Results: There was no significant interaction or group (F-values ranging from .100 
to 1.862, P-values ranging from .754 to .181) effect in CBF or HRV parameters. HRV 
and CBF did change during physical exercise, but the changes did not differ between 
patients and controls. While pain scores during TS at the trapezius site reduced in 
the control group after the physical exercise protocol (P = .037), they did not change 
in the CFS group (P = .108), suggesting impaired pain modulation. There were no 
significant correlations between CBF, HRV, TS, and self-reported symptoms (all P-values 
of correlation analyses > .01).
Limitations: Although effect sizes were medium to large, the study sample was 
relatively low. Also, the mild nature of the exercise bout is discussable. Nonetheless, this 
mild exercise was able to provoke endogenous pain modulation in the control group, 
which endorsed a proper execution of the cycling exercise. Moreover, mild exercises are 
more applicable to daily physical activities in CFS patients than vigorous exercises.
Conclusion: These results seem to refute the previously suggested alterations of CBF/
HRV in CFS patients. These cardiovascular parameters appear not to explain pain before, 
during, and following exercise.
Key words: Chronic pain, physical exercise, emotional stress, pain modulation, 
cardiovascular systems, temporal summation, pain pressure thresholds, transcranial 
Doppler, plethysmography
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However, possible HRV alterations during physical activ-
ity have not been investigated yet. 
Based on the suggested association between car-
diovascular and pain modulatory systems (17) and the 
observation that pain and fatigue (2 core symptoms of 
CFS) are related with symptoms of autonomic dysfunc-
tion (18), alterations in CBF/HRV may explain exercise 
intolerance in CFS patients. Therefore, this study in-
vestigates CBF and HRV in relation to pain modulation 
during a mild physical exercise in CFS patients. Addi-
tionally, the potential association of CBF and HRV pa-
rameters mutually as with self-reported symptoms will 
be considered.
Methods
Study Protocol
The study protocol was performed according to the 
Declaration of Helsinki and was approved by the local 
ethical committee (Universitair Ziekenhuis Brussel/Vrije 
Universiteit Brussel). Before participation, all of the pa-
tients read and signed the informed consent. 
This study was designed as a controlled, random-
ized cross-over trial (see Fig. 1). The patients were ran-
domized (computer-generated randomization list) ac-
cording to the type of stressor that was presented first 
(i.e., emotional stress test or physical exercise). The pa-
tients were asked to sit down in a comfortable position 
for 10 minutes, after which the CBF and HRV recording 
was initiated. Both cardiovascular parameters were 
recorded throughout the whole protocol. First, pain 
pressure thresholds (PPTs) and temporal summation 
(TS) were measured, after which patients underwent a 
physical and emotional stressor in a randomized order. 
In between both stressors, as well as after finalization 
of the last stressor, TS was measured again. All outcome 
measures and the protocol of the used stressors are 
described below. 
Participants 
Female CFS patients and healthy, pain-free, seden-
tary women (age span: 18 – 65 years) were included. 
Only women were included in the present study to 
account for possible gender bias and because of the 
higher prevalence of CFS in women compared to men 
(19). CFS was diagnosed by an experienced physician, 
according to the Centre of Disease Control criteria, 
before study participation. Patients were asked not 
to change or start new treatment (pharmacological or 
other) 4 weeks prior to and during study participation 
Chronic fatigue syndrome (CFS) is a disabling condition, characterized by unexplained, severe fatigue that is not lessened by rest, which 
leads to functional impairment (1). Besides fatigue, 
other symptoms include multi-joint pain, headaches, 
unrefreshing sleep, impaired concentration, and post-
exertional malaise (1). 
Available evidence suggests that these typical 
symptoms are associated with central sensitization 
mechanisms (2), which is characterized by enhanced 
functioning of pain pathways and exercise induced 
hyperalgesia (EIH) (3-5). The latter is thought to result 
from impaired descending inhibiting pathways (central 
pain modulation), leading to greater pain sensitivity 
and severity, which is reflected in the tendency of pain 
thresholds to decrease (instead of increase) in response 
to physical exercise in CFS patients (6). Currently, the 
underlying pathophysiology remains unclear. 
In pain-free people, evidence indicates that experi-
mental pain leads to a decrease in cerebral blood flow 
(CBF) (7), causing symptoms such as fatigue, dizziness, 
memory loss, and headaches. These symptoms, related 
to a decrease in CBF, are also known to be distinctive 
symptoms of CFS, making CBF an element of interest 
for investigation within the CFS population (8). How-
ever, up to now, this was rarely the subject of research. 
Available evidence on CBF in CFS patients suggests an 
abnormal CBF response in different positions (9), but 
CBF has not been investigated in relation to physical ex-
ercise. Yet, as physical exercise is known to evoke typi-
cal symptoms of CFS (due to problems in central pain 
modulation) (10,11) and as pain and fatigue appear to 
be related to changes in CBF, it could be possible that 
inadequate CBF responses to physical exercise are a key 
factor in unravelling the underlying mechanisms of CFS.
Another cardiovascular parameter is heart rate 
variability (HRV). HRV is associated to CBF, is defined as 
the variation over-time of the period between consecu-
tive heartbeats, and represents the well-functioning of 
the autonomic nervous system by giving an impression 
on the balance between the sympathetic and parasym-
pathetic nervous system (12). A balance between these 
2 systems is required to adaptively respond to external 
stressors (13), making HRV a worthwhile parameter to 
investigate as a possible explaining factor in the inabil-
ity of CFS patients to respond adequately to physical 
exercise. In other non-CFS chronic pain populations, 
disruptions in HRV have been shown (13), and similar 
to CBF, CFS patients show an abnormal HRV response 
in certain positions or states (e.g., while asleep) (14-16). 
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Fig. 1. Flow chart of  the study protocol.
TS= temporal summation of pressure pain
in order to obtain a steady state; they could continue 
usual medication. Healthy controls were identified as 
not having a pain-related medical condition as well as 
sedentary, to control for physical fitness. All patients 
were asked to refrain from physical exercise, anal-
gesics, caffeine, alcohol, and nicotine on the day of 
testing.
Exclusion criteria for both groups were: (1) preg-
nancy or delivery in the past year, (2) current use of 
opioid medication, (3) BMI > 30, (4) inability to perform 
a maximal exercise test, or (5) diabetes mellitus. 
Outcomes
Demographic Data 
The collected demographic data included age, 
height, body weight, BMI, and physical activity. To eval-
uate usual physical activity, the Dutch short version of 
the International Physical Activity Questionnaire (IPAQ-
sf) was used. This 7-item questionnaire asks participants 
to write down the amount of days, hours, and minutes 
spent at sitting, walking, moderate activity (e.g., lift-
ing light weights, cycling at moderate speed, etc.), and 
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vigorous activity (e.g., lifting heavy weights, aerobics, 
cycling fast, etc.) during the last 7 days. A higher score 
represents higher physical activity (20) . The IPAQ-sf has 
a good test-retest reliability and a moderate criterion 
validity in healthy adults (20).
HRV and CBF
The Nexfin (BMEYE, Amsterdam, The Netherlands) 
was used to obtain data on HRV in resting state and dur-
ing the physical and emotional stress test. This non-in-
vasive device uses finger plethysmography measurement 
and has been validated previously (21). HRV assessment 
comprises analysis of the intervals between consecutive 
systolic peaks (P wave to P wave or normal-to-normal 
intervals). A major advantage of this assessment is its 
reproducibility, but the recording duration varies signifi-
cantly between studies. HRV assessment can include time 
domain analysis, frequency domain analysis, nonlinear 
analysis, and time-frequency analysis. Recordings were 
visualized and processed using HRV Analysis Software 
(HRVAS). For each condition an artefact-free segment 
with a duration of 5 minutes was chosen for the analysis, 
in order to correct for noise or extrabeats, etc (22).
CBF was continuously monitored using transcranial 
Doppler echography (SONARA™, Viasys Healthcare Inc., 
Conshohocken, PA). Insonating both middle cerebral ar-
teries mean velocity (MV), pulsatility index (PI), resistance 
index (RI), and heart rate were continuously registered. 
The average of the last recorded 5 minutes of each condi-
tion were processed and used in the analysis (46). Both PI 
and RI are associated with vascular resistance, referring 
to the resistance that must be overcome to create blood 
flow. Transcranial Doppler shows good validity in mea-
suring CBF and is representative of CBF velocity (23). CBF 
changes as measured in the middle cerebral arteries are 
supposed to represent changes in brain perfusion as the 
diameter of such great arteries is invariable. The perfu-
sion territory of these arteries covers lateral parts of the 
cortex, including the primary somatosensory cortex, the 
inferior parietal lobe, the insular cortex, and parts of the 
prefrontal cortex among others. Two 2MHz probes were 
held in fixed position over the left and right temporal 
bone window. The angles and the insonation depth of 
the transcranial Doppler transducer were modified until 
the correct flow was found.
PPTs and TS of Pressure Pain
TS of pressure pain was used to evaluate the excit-
ability of the dorsal horn neurons and the functionality 
of pain modulation during physical exercise. When pain 
modulation is working adequately, one would expect 
a reduction in pain scores related to the TS protocol. 
First the PPTs, which are defined as the minimal 
pressure inducing pain, were determined using a 
digital Fisher algometer (FPXTM, Wagner Instruments, 
Greenwich, CT) applied on both the trapezius (between 
the processus spinosus C7 and the acromio-clavicular 
joint) and quadriceps (halfway between the spina iliaca 
anterior superior and the patella). These 2 test sites 
were assessed in randomized order and the PPT was 
measured twice per test site, after which the mean was 
calculated and used in the analysis. To obtain the PPT, 
pressure was increased at a constant rate of 1 kg/s until 
the patient indicated an unpleasant, but not yet pain-
ful feeling. The procedure for determining the PPT and 
the TS of pressure pain is described in detail elsewhere 
by Cathcart et al (24). To assess TS, 10 stimuli were given 
with the algometer at the PPT intensity with an inter-
stimulus interval of one second. Patients were asked 
to rate the first, fifth, and tenth stimulus on a scale 
from 0 to 10 (10 being highly unpleasant), and TS was 
obtained by extracting the first score from the last. This 
procedure has been found reliable in healthy patients 
and has been repeatedly used for studying patients 
with chronic pain, including CFS (25).
Self-Reported Symptoms
The patients were asked to rate pain severity, fa-
tigue severity, and concentration difficulties (main CFS 
symptoms) on a scale from one to 10 before the start of 
the experimental protocol, as well as immediately af-
ter, 24 hours, and 48 hours after finishing the protocol.
Stressors
Physical Stressor
All patients performed a mild cycling exercise on 
a Monark ergometer with a large flywheel (Monark 
Exercise AB, Sweden). The seat was adjusted to the 
level of the greater trochanter. All of the patients 
performed a submaximal exercise test of 12 minutes 
cycling at 55–65 cycles per minute, against a constant 
resistance of 50 W. 
Emotional Stressor
The International Affective Picture System (IAPS) 
(26) was used as the emotional stressor, to control for 
potential bias. The protocol is well-described by Lang 
et al (26) and was used as such in this study. The IAPS 
provides a standardized set of photographic slides 
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that vary in emotional evocation. The pictures include 
mutilated faces, burn victims, accidents, etc. and were 
presented for 6 seconds followed by a white screen. The 
mean inter-picture interval is 12 seconds. The patients 
were asked to watch closely and to let the pictures ‘sink 
in.’ Afterwards, they were asked to give the picture 
a score ranging from 1 to 9, with 9 being highly un-
pleasant. This system is a well-validated research-based 
inventory (26).
Statistical Analysis
Data were analyzed using SPSS Version 22.0 (IBM 
Corporation, Armonk, NY). Comparability of the 
groups at baseline was assessed using the indepen-
dent t-test or Mann-Whitney U-test, depending on 
the normality of the data.  Possible alterations in CBF, 
HRV, and TS during physical and emotional stress were 
assessed using a repeated-measure ANCOVA (group x 
stressor), with significance set at P < .05. Physical activ-
ity (IPAQ-sf) was added as a covariate. The assumption 
of homogeneity and sphericity was checked by Levene’s 
and Mauchly’s test, respectively. Greenhouse-Geisser 
corrections were used when sphericity was violated. 
Post-hoc analysis was performed using Bonferroni. In 
the CFS group, correlation analysis (Pearson or Spear-
man respectively) was performed to examine the as-
sociation between changes in CBF, HRV, self-reported 
post-exertional malaise, and EIH (change in TS due to 
physical exercise). To correct for multiple comparisons, 
correlations were only deemed significant below the 
0.01 level (2-tailed). 
Results
Subject Characteristics and Comparability
Twenty female CFS patients and 20 female seden-
tary pain-free controls were included. The patients and 
controls were comparable for demographic variables. 
The groups differed at baseline for the PPT measured 
at the trapezius site (P = .002), and self-reported symp-
toms of pain, fatigue, and concentration difficulties 
were significantly higher in CFS patients at each point 
of measurement (P < .002). On average, CFS patients 
reported a pain score of 6 out of 10 at baseline, which 
relates to severe pain; details can be found in Table 1.
HRV Response in CFS
No significant group or interaction effect was 
seen for HRV parameters. The main effect of condition 
was significant in several HRV parameters, including 
time-domain standard deviation of all NN intervals 
(SDNN) (Df = 1.364; F = 10.511; P = .001) and triangular 
interpolation of the NN interval histogram (TINN) (Df 
= 1.450; F = 8.053; P = .004), frequency-domain low 
frequency/high frequency (LF/HF) ratio (Df = 1510; F = 
4.495; P = .027) and nonlinear alpha-1 (Df = 1.449; F = 
40.806; P < .001), and time-frequency LF/HF ratio (Df 
= 1.352; F = 6.026; P = .013). Details on the ANCOVA 
results and Bonferroni post-hoc analysis can be found 
in Table 2. 
CBF Response in CFS
Similarly, for CBF, no main group effects or interac-
tion effects were found. For all parameters, the main 
effect of condition was significant (F-values ranging 
from 4.524 to 184.849; P-values ranging from .014 to < 
.001) (Table 3). Bonferroni post-hoc tests revealed that 
all CBF parameters showed a significant increase from 
baseline to physical exercise (P-values ranging from .005 
to < .001), while CBF parameters did not significantly 
differ between baseline and the emotional stressor 
(P-values ranging from .291 to 1.000), except for heart 
rate (P < .001).
TS of Pressure Pain in CFS
For the changes in TS, a significant interaction 
effect was found for both the quadriceps (Df = 2; F 
= 3.213; P = .046) and trapezius (Df = 2; F = 5.07; P = 
.009) (Table 4). Post-hoc analysis of the interaction ef-
fect only showed a significant decrease in TS (trapezius 
site) between baseline and both physical (P = .037) and 
emotional stress (P = .005) in the control group (see Fig. 
2 and data in supplementary material S1). 
Associations between Changes in CBF, HRV, and TS
No significant correlations were observed between 
changes in CBF, HRV, or TS within or across conditions 
(all P > .01).
Self-Reported Symptoms and the Associations 
with CBF and HRV
No significant correlations were observed between 
self-reported concentration difficulties, fatigue, and 
pain, with CBF or HRV parameters at baseline, during 
physical exercise, or the change in these parameters 
(from baseline to physical exercise) (all P > .01).
discussion 
The aim of this study was to investigate CBF and 
HRV in CFS patients - with regard to EIH and self-re-
ported symptoms - at rest and during physical and emo-
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Table 1. Demographic and clinical characteristics.
Variable
CFS Group
(95% CI)
Control Group
(95% CI)
Mean Difference 
(95% CI)
P-value
Agea (yrs) 41.10 ± 8.90(36.89;44.94)
39.85 ± 14.20 
(33.32;46.20)
-1.25 
(-8.84;6.34) 0.741
Heighta (m) 1.67 ± 0.07 (1.63;1.70)
1.68 ± 0.06 
(1.66;1.71)
0.02 
(-0.03;0.06) 0.427
Weighta (kg) 68.94 ± 11.02 (64.36;73.70)
67.53 ± 8.54 
(63.80;71.40)
-1.41 
(-7.72;4.90) 0.654
BMIa (kg/m2) 24.82 ± 3.46 (23.39;26.39)
23.86 ± 2.93 
(22.61;25.17)
-0.97 
(-3.02;1.09) 0.347
PPT Quadricepsa (kgf) 4.34 ± 2.20 (3.52;5.39)
5.44 ± 1.41 
(4.85;6.05)
1.10 
(-0.09;2.28) 0.068
PPT Trapeziusb (kgf) 1.79 (1.57) (1.73;2.63)
3.04 (1.36) 
(2.84;3.77)
1.14
(0.44;1.84) 0.002
PA Totalb 612.25 (539.30) (478.55;1113.61)
1063.50 (1926.00) 
(1210.24;3112.51)
1264.78 
(229.69;2299.86) 0.068
Post-Exertional Malaiseb 
Pain severity (1–10)
Base 6.00 (3.75) (3.50;6.00)
1.00 (1.00) 
(1.00;1.50)
-3.45 
(-4.66;-2.24) 0.002
0h 6.00 (5.00) (3.50;7.50)
1.00 (0.80) 
(1.00;1.00)
-3.70 
(-5.09;-2.31) < 0.001
24h 6.00 (4.60) (4.50;7.25)
1.00(0.00) 
(--)
-4.83 
(-5.98;-3.64) < 0.001
48h 6.00 (5.00) (3.00;7.00)
1.00 (0.00) 
(--)
-4.40 
(-5.51;-3.29) < 0.001
Post-exertional Malaiseb 
Fatigue severity (1–10)
Base 8.00 (4.00) (6.00;9.50)
2.00 (1.00) 
(1.00;2.00)
-5.55 
(-6.77;-4.33) 0.001
0h 7.50 (2.10) (7.00;8.00)
1.50 (1.80) 
(1.00;2.00)
-5.13 
(-6.16;-4.09) < 0.001
24h 8.00 (1.90) (6.75;8.00)
1.00 (0.00) 
(1.00;1.00)
-5.85 
(-6.71;-4.99) < 0.001
48h 8.00 (1.00) (7.00;8.00)
1.00 (0.00) 
(--)
-6.30 
(-7.08;-5.52) < 0.001
Post-exertional Malaiseb  
Concentration difficulties 
(1–10)
Base 7.00 (4.50) (6.00;9.00)
1.00 (1.00) 
(1.00;2.00)
-5.15 
(-6.51;-3.79) 0.001
0h 6.00 (5.50) (4.50;8.00)
1.00 (1.00) 
(1.00;2.00)
-4.60 
(-5.83;-3.37) < 0.001
24h 6.00 (3.00) 5.00;8.00)
1.00 (0.00) 
(--)
-4.93 
(-6.01;-3.84) < 0.001
48h 6.50 (6.00) (5.00;7.00)
1.00 (0.00) 
(--)
-4.95 
(-5.81;-4.09) < 0.001
Abbreviations: CFS = chronic fatigue syndrome; BMI = body mass index; PPT = pain pressure threshold; PA = physical activity; 0h = symptoms of 
post-exertional malaise reported directly after the experimental protocol; 24h = symptoms of post-exertional malaise reported 24 hours after the 
experimental protocol, 48h = symptoms of post-exertional malaise reported 48 hours after the experimental protocol 
aValues are represented as Mean ± Standard Deviation and comparability of groups was evaluated using the independent t-test. 
bValues are represented as median with interquartile range, and comparability of groups was evaluated using the Mann-Whitney U-test.
tional stress. Overall, results seem to refute a role for 
altered CBF and HRV in CFS patients and do not support 
the hypothesis that EIH and self-reported symptoms are 
associated with altered CBF or HRV. 
HRV and CBF Response in CFS
The present results do not provide evidence for 
altered HRV in CFS patients at rest or during physical 
and emotional stress. Both groups displayed a similar 
and normal reduction of HRV during physical exercise, 
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Table 2. Changes in heart variability in response to a physical vs. emotional stressor in patients with CFS vs. healthy controls.
CFS Patients
Mean ± SD
(95% CI)
Controls
Mean ± SD
(95% CI)
Mean 
Difference
(95%CI)
ANCOVA
Bonferroni Post-Hoc 
Analysis
Interaction 
Effect
Physical 
Activity 
Effect
Main 
Effect 
of  Exp. 
Condition
Main 
Effect of  
Group
Base vs. 
Phys
Base vs. 
Emo
Phys vs. 
Emo
Ti
m
e S
D
N
N
Base 53.21 ± 23.69 (41.13;66.73)
52.20 ± 24.96 
(39.86;66.99)
-0.76 
(-21.91;20.40)
NS
Df = 1.364
F = 0.483
P = 0.550
ηp2 = 0.021
Df = 1.364
F = 10.511
P = 0.001
ηp2 = 0.323
Df = 1
F = 0.979
P = 0.333
ηp2 = 0.043
P < 0.001 P = 0.025 P < 0.001Phys 24.32 ± 11.63 (18.42;31.25)
21.48 ± 8.27 
(17.17;25.17)
-3.48 
(-12.22;5.19)
Emo 47.44 ± 20.13 (37.15;58.05)
41.90 ± 19.54 
(31.56;52.77)
-6.13 
(-23.26;11.01)
Ti
m
e R
M
SS
D Base
35.79 ± 18.64 
(26.32;46.56)
34.08 ± 20.90 
(23.07;46.19)
-2.78 
(-19.71;14.14)
NS
Df = 1.173
F = 0.472
P = 0.528
ηp2 = 0.021
Df = 1.173
F = 2.509
P = 0.121
ηp2 = 0.102
Df = 1
F = 0.813
P = 0.377
ηp2 = 0.036
N/A N/A NAPhys 20.46 ± 10.94 (14.93;26.98)
21.49 ± 7.99 
(17.22;25.75)
1.52 
(-6.76;9.79)
Emo 30.45 ± 12.75 (23.48;37.52)
28.03 ± 20.39 
(17.54;39.72)
-3.25 
(-17.87;11.21)
Ti
m
e T
IN
N
Base 187.86 ± 118.47 (132.92;254.88)
162.84 ± 74.57 
(124.96;207.81)
-21.47 
(-107.59;64.66)
NS
DF = 1.450
F = 0.408
P = 0.603
ηp2 = 0.018
Df = 1.450
F = 8.053
P = 0.004
ηp2 = 0.268
Df = 1
F = 0.881
P = 0.358
ηp2 = 0.038
P < 0.001 P = 0.399 P < 0.001Phys 63.27 ± 34.90 (44.49;82.71)
68.43 ± 39.97 
(45.72;89.75)
4.06 
(-28.23;36.35)
Emo 166.76 ± 84.16 (123.88;212.29)
145.16 ± 88.17 
(96.82;192.83)
-25.11 
(-99.23;49.01)
Fr
eq
 A
R 
LF
H
F Base
2.55 ± 2.04 
(1.66;3.77)
2.86 ± 1.36 
(2.18;3.65)
0.79 
(-0.27;1.86)
NS
Df = 1.510
F = 1.080
P = 0.335
ηp2 = 0.047
Df = 1.510
F = 4.495
P = 0.027
ηp2 = 0.170
Df = 1
F = 0.176
P = 0.679
ηp2 = 0.008
P = 0.262 P = 0.527 P = 0.097Phys 2.21 ± 1.57 (1.46;3.00)
1.72 ± 1.57 
(1.03;2.65)
-.031 
(-1.61;0.99)
Emo 2.90 ± 1.65 (2.10;3.86)
3.33 ± 2.02 
(2.27;4.49)
0.69 
(-0.78;2.17)
Po
in
ca
re
 S
D
1 Base
25.33 ± 13.21 
(19.13;33.50)
24.13 ± 14.80 
(16.65;32.98)
-1.97 
(-13.96;10.02)
NS
Df = 1.172
F = .473
P = 0527
ηp2 = 0.021
Df = 1.172
F = 2.503
P = 0.122
ηp2 = 0.102
Df = 1
F = 0.806
P = 0.379
ηp2 = 0.035
N/A N/A N/APhys 14.48 ± 7.75 (10.13;18.43)
15.22 ± 5.66 
(12.15;18.42)
1.08 
(-4.78;6.95)
Emo 21.56 ± 9.04 (17659;26.99)
19.84 ± 14.45 
12.91;28.64)
-2.30 
(-12.55;7.95)
N
on
lin
ea
r S
am
pe
n Base 2.38 ± 0.66 (2.14;2.79)
2.32 ± 0.65 
(1.96;2.66)
-0.14 
(-0.68;0.40)
NS
Df = 1.585
F = 0.274
P = 0.710
ηp2 = 0.012
Df = 1.585
F = 1.311
P = 0.277
ηp2 = 0.056
Df = 1
F = 1.329
P = 0.261
ηp2 = 0.057
N/A N/A N/APhys 2.03 ± 0.40 (1.80;2.24)
2.05 ± 0.38 
(1.83;2.26)
0.03 
(-0.31;0.37)
Emo 2.35 ± 0.47 (2.08;2.60)
2.12 ± 0.37 
(1.92;2.33)
-0.21 
(-0.57;0.16)
N
on
lin
ea
r A
lp
ha
 1 Base 1.17 ± 0.28 (0.99;1.28)
1.26 ± 0.17 
(1.16;1.35)
0.12 
(-0.07;0.31)
NS
Df = 1.449
F = 1.586
P = 0.222
ηp2 = 0.067
Df = 1.449
F = 40.806
P < 0.001
ηp2 = 0.650
Df = 1
F = 0.100
P = 0.754
ηp2 = 0.005
P < 0.001 P = 0.148 P < 0.001Phys 0.76 ± 0.19 (0.68;0.88)
0.72 ± 0.21 
(0.60;0.83)
-0.06 
(-0.23;0.10)
Emo 1.28 ± 0.19 (1.16;1.35)
1.30 ± 0.20 
(1.19;1.41)
0.05 
(-0.12;0.20)
Ti
m
e F
re
q 
A
R 
rL
FH
F
Base 4.44 ± 5.05 (2.03;7.45)
5.36 ± 4.55 
(3.27;8.05)
0.93 
(-3.14; 4.99)
NS
Df = 1.352
F = 0.688
P = 0.456
ηp2 = 0.032
Df = 1.352
F = 6.026
P = 0.013
ηp2 = 0.223
Df = 1
F = 0.118
P = 0.734
ηp2 = 0.006
P = 0.015 P = 0.218 P = 0.043Phys 1.84 ± 1.22 (1.24;2.58)
1.65 ± 1.12 
(1.16;2.39)
-0.19 
(-1.18;0.80)
Emo 2.73 ± 1.55 (1.99;3.63)
3.32 ± 2.04 
(2.23;4.46)
0.59 
(-0.95;2.12)
Abbreviations: CFS = chronic fatigue syndrome; ηp2 = partial eta squared (effect size); Base = baseline value; Phys = value measured during physical 
stressor; Emo = value measured during emotional stressor; SDNN = standard deviation of all NN intervals; rMSSD = the root-mean-square of 
differences of adjacent NN intervals; TINN = triangular interpolation of NN interval; rLFHF = ratio low frequency/high frequency; NS = not 
significant; N/A = not applicable
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Table 3. Changes in CBF in response to physical vs. emotional stressor in patients with CFS vs. healthy controls.
CFS patients
Mean ± SD
(95% CI)
Controls
Mean ± SD
(95% CI)
Mean 
Difference
(95% CI)
ANCOVA Bonferroni Post-Hoc Analysis
Interaction 
Effect
Physical 
Activity 
Effect
Main 
Effect 
of  Exp. 
Condition
Main 
Effect of  
Group
Base vs. 
Phys
Base vs. 
Emo
Phys vs. 
Emo
M
V
 R
Base 54.95 ± 10.69 (50.32;60.93)
59.12 ± 14.05 
(52.47;65.03)
3.52 
(-5.23;12.27)
NS
Df=2
F = 0.375
P = 0.689
ηp2 = 0.010
Df = 2
F = 5.915
P = 0.004
ηp2 = 0.138
Df = 1
F = 0.889
P = 0.352
ηp2 = 0.023
P < 0.001 P = 1.000 P = 0.003Phys 58.38 ± 13.01 (52.65;65.04)
64.03 ± 14.85 
(57.36;71.05)
5.53 
(-4.17;15.22)
Emo 55.94 ± 11.27 (50.18;61.06)
59.94 ± 13.03 
54.11;66.78)
4.74 
(-4.12;13.60)
M
V
 L
Base 56.17 ± 11.22 (51.01;61.52)
59.06 ± 12.90 
(53.35;64.63)
2.89 
(-5.30;11.08)
NS
Df = 2
F = 0.199
P = 0.820
ηp2 = 0.006
Df = 2
F = 4.524
P = 0.014
ηp2 = 0.121
Df = 1
F = 0.384
P = 0.540
ηp2 = 0.011
P = 0.005 P = 1.000 P = 0.002Phys 59.17 ± 12.90 (53.32;65.46)
62.87 ± 12.73 
(57.19;68.41)
3.70 
(-4.98;12.38)
Emo 55.88 ± 11.85 (50.50;61.49)
58.72 ± 12.47 
(53.27;64.56)
2.84 
(-5.40;11.08)
PI
 R
Base 0.87 ± 0.18 (0.81;0.98)
0.96 ± 0.18 
(0.89;1.06)
0.07 
(-0.05;0.20)
NS
Df = 2
F = 0.444
P = 0.643
ηp2 = 0.012
Df = 2
F = 64.355
P < 0.001
ηp2 = 0.635
Df = 1
F = 1.862
P = 0.181
ηp2 = 0.048
P < 0.001 P = 0.291 P < 0.001Phys 1.18 ± 0.27 (1.07;1.33)
1.23 ± 0.18 
(1.17;1.31)
0.04 
(-0.11;0.19)
Emo 0.84 ± 0.16 (0.79;0.93)
0.90 ± 0.16 
(0.84;0.99)
0.05 
(-0.06;0.16)
PI
 L
Base 0.90 ± 0.22 (0.82;1.01)
0.94 ± 0.22 
(0.85;1.03)
0.03 
(-0.12;0.18)
NS
Df = 1.648
F = 0.596
P = 0.523
ηp2 = 0.018
Df = 1.648
F = 38.229
P < 0.001
ηp2 = 0.537
Df = 1
F = 0.087
P = 0.770
ηp2 = 0.003
P < 0.001 P = 1.000 P < 0.001Phys 1.28 ± 0.34 (1.14;1.46)
1.26 ± 0.19 
(1.19;1.34)
-0.02 
(-0.21;0.16)
Emo 0.93 ± 0.26 (0.83;1.07)
0.87 ± 0.11 
(0.82;0.92)
-0.06 
(-0.20;0.07)
RI
 R
Base 0.55 ± 0.06 (0.53;0.58)
0.58 ± 0.04 
(0.56;0.59)
0.02 
(-0.01;0.05)
NS
Df = 2
F = 0.066
P = 0.936
ηp2 = 0.002
Df = 2
F = 64.657
P < 0.001
ηp2 = 0.636
Df = 1
F = 0.953
P = 0.335
ηp2 = 0.025
P < 0.001 P = 0.345 P < 0.001Phys 0.65 ± 0.07 (0.62;0.68)
0.66  0.03 
(0.65;0.68)
0.01 
(-0.02;0.05)
Emo 0.55 ± 0.07 (0.53;0.59)
0.56  0.05 
(0.54;0.58)
0.00 
(-0.03;0.04)
RI
 L
Base 0.57  0.07 (0.54;0.61)
0.57 ± 0.05 
(0.55;0.59)
-0.00 
(-0.05;0.04)
NS
Df = 1.707
F = 0.193
P = 0.791
ηp2 = 0.006
Df = 1.707
F = 30.523
P < 0.001
ηp2 = 0.481
Df = 1
F = 0.033
P = 0.857
ηp2 = 0.001
P < 0.001 P = 0.965 P < 0.001Phys 0.67 ± 0.07 (0.64;0.70)
0.67  0.04 
(0.66;0.69)
0.00 
(-0.03;0.04)
Emo 0.56 ± 0.07 (0.53;0.60)
0.56  0.05 
(0.54;0.58)
-0.00 
(-0.04;0.04)
H
R
Base 76.78 ± 11.39 (72.33;82.80)
79.48 ± 12.70 
(74.30;85.89)
2.85 
(-5.46;11.17)
NS
Df = 1.239
F = 1.800
P = 0.186
ηp2 = 0.046
Df = 1.239
F = 184.849
P < 0.001
ηp2 = 0.833
Df = 1
F < 0.001
P = 0.993
ηp2 < 0.001
P < 0.001 P < 0.000 P < 0.001Phys 125.97 ± 20.85 (117.77;136.43)
122.67 ± 18.70 
(112.71;129.59)
-6.01 
(-19.53;7.51)
Emo 82.54 ± 13.98 (77.04;90.05)
83.22 ± 12.36 
(76.86;88.36)
-0.37 
(-9.93;8.88)
Abbreviations: CFS = chronic fatigue syndrome; ηp2 = partial eta squared (effect size); R = right; L = left; MV = mean cerebral blood flow velocity; 
PI = pulsatility index; RI = resistance index; HR = heart rate; Base = baseline value; Phys = value measured during physical stressor; Emo = value 
measured during emotional stressor; NS= not significant
which normalizes (back to baseline values) again during 
emotional stress. Similar findings have been reported 
for supine position and upright tilt (14). These results 
refute our hypothesis of altered HRV as seen in other 
chronic pain populations (17,18). 
Likewise, none of the CBF parameters differed 
between the CFS patients and healthy controls, and 
both of the groups showed a similar evolution in CBF 
parameters over the different experimental conditions. 
CBF data of the study population was within normal 
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Table 4. Changes in TS in response to physical vs. emotional stressor in patients with CFS vs. healthy controls.
CFS Patients
Mean ± SD
(95% CI)
Controls
Mean ± SD
(95% CI)
Mean 
Difference
(95% CI)
ANCOVA
Bonferroni Post-
Hoc AnalysisInteraction 
Effect
Physical 
Activity 
Effect
Main 
Effect 
of  Exp. 
Condition
Main 
Effect of  
Group
M
. Q
ua
dr
ic
ep
s Base 2.88 ± 1.87 (2.07;3.71)
1.25 ±0.92 
(0.86;1.69)
-1.61 
(-2.58;-0.64) Df = 2
F = 0.106
P = 0.046
ηp2 = 0.078
NS N/A N/A
See Fig. 2.
Data presented in 
supplementary material 
S1.
Phys 2.95 ± 1.98 (2.05;3.79)
1.23 ±0.98 
(0.81;1.71)
-1.71 
(-2.74;-0.69)
Emo 2.95 ± 1.79 (2.20;3.71)
1.40 ± 1.23 
(0.88;1.95)
-1.56 
(-2.56;-0.55)
M
. T
ra
pe
zi
us
Base 2.78 ± 1.36 (2.16;3.38)
1.71 ± 1.21 
(1.18;2.29)
-1.06 
(-1.90;-0.22) Df = 2
F = 5.07
P = 0.009
ηp2 = 0.121
NS N/A N/A
See Fig. 2.
Data presented in 
supplementary material 
S1.
Phys 3.30 ± 1.70 (2.55;4.11)
1.00 ± 1.15 
(.53;1.59)
-2.30 
(-3.25;-1.35)
Emo 3.00 ± 1.31 (2.38;3.59)
0.76 ± 1.08 
(0.27;1.29)
-2.24 
(-3.02;-1.46)
Abbreviations: CFS = chronic fatigue syndrome; M.Quadriceps = temporal summation measured at the quadriceps site; M.Trapezius = temporal 
summation measured at the trapezius site; Base = baseline value; Phys = value measured directly after physical exercise; Emo = value measured 
directly after emotional stress test; ηp2 = partial eta squared (effect size); NS = not significant; N/A = not applicable
Fig. 2. Changes in TS.
age cohort ranges (27). These findings reject our hy-
pothesis that a smaller CBF increase could explain the 
intolerance for physical exertion in CFS patients. This is 
in line with previous findings showing no altered CBF in 
CFS patients in supine position or in response to ortho-
static stress (9,28). However, the study of Stewart et al 
(9) observed a lower absolute CBF velocity in response 
to incremental upright tilt combined with cognitive 
activation. There is some evidence for the influence of 
cognitive tasks on CBF alterations in chronic pain, pro-
viding an explanation for significantly lower CBF in CFS 
patients in Stewart et al (9), which was not observed in 
the present study. To conclude, it appears that HRV and 
CBF are within normal ranges at rest and in response to 
mild exercise in patients with CFS.
TS of Pressure Pain
TS of pressure pain at baseline was significantly 
higher in CFS patients when compared to healthy 
controls at both measurement sites, confirming previ-
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ous findings of pressure hyperalgesia (6). During the 
TS protocol, 10 stimuli were given at a constant rate 
of one stimulus per second. In case of normal nocicep-
tive processing, the pain score that a person gives to 
the consecutive stimuli will increase with every given 
stimulus. In case of abnormal nociceptive processing, 
this pain score will increase more intensely. This is 
reflected in the higher TS scores (visual analog scale 
[VAS] score at the tenth stimulus minus VAS score at the 
first stimulus) in CFS patients compared to the control 
group. Additionally, TS scores decreased after physi-
cal exercise in the control group, while they tended 
to increase in the CFS group). In healthy persons, the 
descending pain modulation becomes active because of 
physical exercise, which is reflected in a smaller increase 
of pain scores, resulting in a lower TS score. In CFS pa-
tients however, this score increased, which suggests the 
presence of EIH and dysfunctional pain modulation in 
CFS patients as reported previously (6).
Association between EIH and CBF or HRV
Contrary to the a priori set hypotheses, no associa-
tions were found between EIH and CBF or HRV in CFS 
patients, neither at rest nor in response to physical/
emotional stress. These results again seem to refute a 
role for CBF or HRV in explaining pain increases follow-
ing exercise or emotional stress in CFS patients.
Cerebral autoregulation aims at maintaining the 
CBF adequate and stable. The perfusion pressure must 
be within autoregulatory range (60–160 mmHg) to be 
effective (29). This range may be exceeded during mod-
erate or intense exercise. The baroreceptor reflex plays 
an important role in the regulation of CBF when this 
range is exceeded. One of the characteristics of CFS is a 
reduced baroreceptor reflex sensitivity (30), which may 
contribute to exaggerated pain sensitivity and typical 
EIH in these patients. In the present study, using a mild 
physical exercise, patients likely did not go beyond 
their autoregulatory range. This may explain why CBF 
parameters remained unaltered and why no association 
with EIH was found. Additionally, as evidence suggests 
that autonomic control is important for CBF regulation 
during exercise, it seems acceptable that when CBF is 
not related to EIH, this relation is also not seen for HRV 
(29).
Association between CBF or HRV and Self-
Reported Symptoms
Although CFS patients reported high pain sever-
ity, fatigue severity, and concentration difficulties 
before, during, and following study participation, no 
association was found with CBF or HRV parameters at 
the different conditions. This is in line with other results 
reported in the present study, again not supporting a 
role for altered CBF or HRV in explaining pain increases 
and other symptoms following exercise or emotional 
stress in CFS patients.
Strengths, Limitations, and 
Recommendations for Further Research
This is the first study investigating CBF in CFS pa-
tients during physical exercise and emotional stress 
using transcranial Doppler, a method chosen for its 
real-time ability to monitor CBF across conditions and 
its superior time resolution. 
Previous exercise physiological studies on CFS used 
case-control rather than experimental designs (31,32). 
This implies that previous observations regarding ex-
ercise physiology in CFS patients did not control for 
potential bias of emotional stressors or the fluctuating 
nature of CFS. Therefore, this study comprises a true ex-
perimental design (randomized cross-over) controlling 
for emotional stressors. Also, valid methods were used 
for examining TS of pressure pain, CBF, and HRV and 
for triggering emotional stress as control condition. The 
measurements’ validity is also supported by the highly 
experienced staff within CBF and HRV measurements 
(experienced research nurses supervised by neurolo-
gists). Additionally, CBF data did not show relevant dif-
ferences between the left and right side, and both CBF 
and HRV values fit within reported reference values 
(33). Last, the present study included only women, cor-
recting for possible gender effects. 
Some limitations are worth mentioning. Even 
though the effect sizes of results were medium to 
large, the study sample is relatively low. Also, the 
mild nature of the exercise bout can be discussed. 
However, this mild exercise was able to induce en-
dogenous pain modulation in the healthy controls, 
which endorses the proper execution of the exercise 
bout. Moreover, mild exercises are more applicable 
to daily physical activities in CFS patients than vigor-
ous exercises. Yet, further research may determine 
whether a higher effort induces disruption in CBF/
HRV parameters, and if this is associated with EIH 
in CFS patients. Furthermore, the phase of the men-
strual cycle, which is a potential influential factor 
of pain due to the potential influence of hormones 
on the pain experience, was not taken into account 
in the present study and should be considered in 
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future research. Additionally, although CFS patients 
share many symptom similarities with other chronic 
pain populations (34), they constitute a specific pain 
population. Hence, the study findings cannot be ex-
trapolated to the general chronic pain population. Fi-
nally, the clinical relevance of these findings requires 
discussion. The aim of this study was to clarify the 
still largely unknown underlying pathophysiological 
mechanisms behind post-exertional malaise and EIH 
in CFS. Improved understanding of these mechanisms 
might lead to improved care when suitable treat-
ments can restore dysfunctional mechanisms. Based 
on the present study findings, treatments that aim to 
improve CBF or dysautonomia are not indicated for 
treating EIH in people with CFS.
conclusion 
CFS patients do not show decreased CBF or HRV 
during mild physical exercise or emotional stress and 
no association was observed with EIH or self-reported 
symptoms. These results seem to reject a role for CBF 
and HRV in explaining pain increases during and fol-
lowing physical exercise in CFS patients. 
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